Acquired by Celera in 2007, the company is a healthcare technology & services company that provides cardiovascular disease management, with a unique focus on the secondary prevention market through a combination of proprietary lipid testing technology, esoteric testing capability, advanced therapy guidelines, sophisticated informatic tools, and patient support services.
